Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,220.00
0.00 (0.00%)
Sep 11, 2026, 3:30 PM KST

Bio Plus Revenue

Bio Plus had revenue of 25.40B KRW in the quarter ending June 30, 2026, with 22.87% growth. This brings the company's revenue in the last twelve months to 99.15B, up 11.20% year-over-year. In the year 2025, Bio Plus had annual revenue of 90.90B with 36.87% growth.

Revenue (ttm)
99.15B
Revenue Growth
+11.20%
P/S Ratio
2.00
Revenue / Employee
615.85M
Employees
161
Market Cap
198.16B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.90B24.49B36.87%
Dec 31, 202466.41B1.37B2.10%
Dec 31, 202365.04B8.32B14.68%
Dec 31, 202256.72B19.30B51.58%
Dec 31, 202137.42B13.05B53.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Value Added Technology441.04B
Vieworks244.28B
Boditech Med174.78B
WON TECH167.35B
Dongbang Medical125.12B
Shinhung105.89B
Curexo77.74B
JETEMA,76.58B
Revenue Rankings